• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳铁蛋白修饰脂质体作为一种新型载体改善脑内递药的体内外评价

In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery.

机构信息

Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan.

出版信息

Int J Mol Sci. 2013 Jan 29;14(2):2862-74. doi: 10.3390/ijms14022862.

DOI:10.3390/ijms14022862
PMID:23434652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3588019/
Abstract

In this study, lactoferrin-conjugated PEGylated liposomes (PL), a potential drug carrier for brain delivery, was loaded with radioisotope complex, 99mTc labeled N,N-bis(2-mercaptoethyl)-N',N'-diethylethylenediamine (99mTc-BMEDA) for in vitro and in vivo evaluations. The hydrophilicity of liposomes was enhanced by PEGylation which was not an ideal brain delivery system for crossing the blood brain barrier (BBB). With the modification of a brain-targeting ligand, lactoferrin (Lf), the PEGylated liposome (PL) might become a potential brain delivery vehicle. In order to test the hypothesis in vitro and in vivo, 99mTc-BMEDA was loaded into the liposomes as a reporter with or without Lf-conjugation. The mouse brain endothelia cell line, bEnd.3 cells, was cultured to investigate the potential uptake of liposomes in vitro. The in vivo uptake by the mouse brain of the liposomes was detected by tissue biodistribution study. The results indicated that Lf-conjugated PEGylated liposome showed more than three times better uptake efficiency in vitro and two-fold higher of brain uptake in vivo than PEGlyated liposome. With the success of loading the potential Single Photon Emission Tomography (SPECT) imaging probe, 99mTc-BMEDA, Lf-PL might serve as a promising brain delivery system for loading diagnostics or therapeutics of various brain disorders.

摘要

在这项研究中,乳铁蛋白偶联聚乙二醇化脂质体(PL)作为一种潜在的脑内递药载体,负载放射性同位素复合物 99mTc 标记的 N,N-双(2-巯基乙基)-N',N'-二乙基亚乙基二胺(99mTc-BMEDA)进行体外和体内评价。聚乙二醇化提高了脂质体的亲水性,但它并不是穿越血脑屏障(BBB)的理想脑内递药系统。通过修饰脑靶向配体乳铁蛋白(Lf),聚乙二醇化脂质体(PL)可能成为一种有前途的脑递药载体。为了在体外和体内验证这一假说,将 99mTc-BMEDA 作为报告分子负载到脂质体中,有无 Lf 偶联。培养小鼠脑内皮细胞系 bEnd.3 细胞,以研究脂质体在体外的潜在摄取情况。通过组织生物分布研究检测脂质体在小鼠脑中的体内摄取情况。结果表明,Lf 偶联聚乙二醇化脂质体在体外的摄取效率比聚乙二醇化脂质体高 3 倍以上,体内脑摄取也高 2 倍。由于成功负载了潜在的单光子发射计算机断层扫描(SPECT)成像探针 99mTc-BMEDA,Lf-PL 可能成为一种有前途的脑内递药系统,用于装载各种脑疾病的诊断或治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/b3f0c69baf9b/ijms-14-02862f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/28896f251104/ijms-14-02862f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/dcfbcd06befe/ijms-14-02862f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/98fed5b7a2be/ijms-14-02862f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/967f2faf1d2e/ijms-14-02862f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/13c7c7f6b12e/ijms-14-02862f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/b3f0c69baf9b/ijms-14-02862f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/28896f251104/ijms-14-02862f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/dcfbcd06befe/ijms-14-02862f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/98fed5b7a2be/ijms-14-02862f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/967f2faf1d2e/ijms-14-02862f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/13c7c7f6b12e/ijms-14-02862f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4067/3588019/b3f0c69baf9b/ijms-14-02862f6.jpg

相似文献

1
In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery.乳铁蛋白修饰脂质体作为一种新型载体改善脑内递药的体内外评价
Int J Mol Sci. 2013 Jan 29;14(2):2862-74. doi: 10.3390/ijms14022862.
2
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.乳铁蛋白修饰的前离子脂质体作为一种新型脑递药载体。
Eur J Pharm Sci. 2010 May 12;40(2):94-102. doi: 10.1016/j.ejps.2010.03.007. Epub 2010 Mar 16.
3
Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.采用原位小动物模型评价 PEG 化脂质体嵌入 188Re 对人非小细胞肺癌的治疗和诊断效果。
J Nucl Med. 2014 Nov;55(11):1864-70. doi: 10.2967/jnumed.114.140418. Epub 2014 Oct 27.
4
Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model.(188)Re-BMEDA标记的聚乙二醇化脂质体在C26结肠癌腹水小鼠模型腹腔注射后的生物分布、药代动力学及成像
Nucl Med Biol. 2007 May;34(4):415-23. doi: 10.1016/j.nucmedbio.2007.02.003.
5
Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.将锝-99m和铼-186/188放射性核素载入预制脂质体用于诊断成像和放射性核素治疗的技术。
Methods Mol Biol. 2017;1522:155-178. doi: 10.1007/978-1-4939-6591-5_13.
6
Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.乳铁蛋白修饰的聚乙二醇脂质体对肝癌的靶向作用。
Eur J Pharm Sci. 2012 Jun 14;46(3):131-41. doi: 10.1016/j.ejps.2012.02.007. Epub 2012 Feb 20.
7
"Guide" of muscone modification enhanced brain-targeting efficacy and anti-glioma effect of lactoferrin modified DTX liposomes.麝香酮修饰的“导向”增强了乳铁蛋白修饰的多西他赛脂质体的脑靶向疗效和抗胶质瘤作用。
Bioeng Transl Med. 2022 Aug 18;8(2):e10393. doi: 10.1002/btm2.10393. eCollection 2023 Mar.
8
[In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].乳铁蛋白修饰的聚乙二醇化脂质体对肝癌细胞的体外靶向作用
Yao Xue Xue Bao. 2015 Oct;50(10):1272-9.
9
A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.一种新型乳铁蛋白修饰的隐形脂质体,用于三碘甲状腺原氨酸的肝癌递药。
Int J Pharm. 2018 Feb 15;537(1-2):257-267. doi: 10.1016/j.ijpharm.2017.12.048. Epub 2017 Dec 30.
10
A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation.一种使用99mTc-"SNS/S"复合物的新型脂质体放射性标记方法:体内外评估
J Pharm Sci. 2003 Sep;92(9):1893-904. doi: 10.1002/jps.10441.

引用本文的文献

1
Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer's Disease.功能化纳米颗粒:有效管理阿尔茨海默病的一种有前景的方法。
Mol Neurobiol. 2025 Apr 16. doi: 10.1007/s12035-025-04917-2.
2
Lactoferrin-modified PLGA nanoparticles for pregabalin: development, characterization, in vitro targeting and pharmacodynamic evaluation.用于普瑞巴林的乳铁蛋白修饰聚乳酸-羟基乙酸共聚物纳米粒:制备、表征、体外靶向性及药效学评价
Drug Deliv Transl Res. 2025 Apr 8. doi: 10.1007/s13346-025-01848-2.
3
Molecular Characterization and Expression of Lactoferrin Receptor (LfR) in Different Regions of the Brain Responding to Lactoferrin Intervention.

本文引用的文献

1
Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.(188)Re 标记的聚乙二醇化纳米脂质体在荷原位脑胶质瘤大鼠模型中的成像、放射自显影和生物分布。
Cancer Biother Radiopharm. 2011 Dec;26(6):717-25. doi: 10.1089/cbr.2011.1052.
2
Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.乳铁蛋白修饰的多柔比星载前体脂质体用于治疗神经胶质瘤。
Eur J Pharm Sci. 2011 Sep 18;44(1-2):164-73. doi: 10.1016/j.ejps.2011.07.007. Epub 2011 Jul 18.
3
Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo.
乳铁蛋白受体(LfR)在脑不同区域对乳铁蛋白干预的分子特征及表达
Mol Neurobiol. 2025 Mar;62(3):2857-2871. doi: 10.1007/s12035-024-04378-z. Epub 2024 Aug 24.
4
Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.揭示关联:2型糖尿病与帕金森病——一种基于纳米的靶向药物递送方法
Curr Diabetes Rev. 2025;21(6):32-58. doi: 10.2174/0115733998291968240429111357.
5
Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer's Disease: Superior Efficacy of Extracellular Vesicles Over Polymeric Nanoparticles.用于治疗阿尔茨海默病的载多奈哌齐纳米载体:细胞外囊泡比聚合物纳米颗粒具有更高的疗效
Int J Nanomedicine. 2024 Feb 1;19:1077-1096. doi: 10.2147/IJN.S449227. eCollection 2024.
6
Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease.乳铁蛋白修饰的黄连素纳米脂质体增强了阿尔茨海默病小鼠模型中的神经保护作用。
Neural Regen Res. 2023 Jan;18(1):226-232. doi: 10.4103/1673-5374.344841.
7
Chemical Conjugation in Drug Delivery Systems.药物递送系统中的化学偶联
Front Chem. 2022 May 26;10:889083. doi: 10.3389/fchem.2022.889083. eCollection 2022.
8
The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges.脂质体纳米制剂优化三萜类化合物的递送:克服挑战。
Int J Mol Sci. 2022 Jan 20;23(3):1140. doi: 10.3390/ijms23031140.
9
Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain.用于将利鲁唑递送至脑部的乳铁蛋白功能化脂质纳米粒的制剂、表征及细胞毒性评价
Pharmaceutics. 2022 Jan 13;14(1):185. doi: 10.3390/pharmaceutics14010185.
10
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.纳米药物的脑内递送:用于脑部质粒DNA基因治疗的特洛伊木马脂质体
Front Med Technol. 2020 Nov 16;2:602236. doi: 10.3389/fmedt.2020.602236. eCollection 2020.
乳铁蛋白偶联超顺磁性氧化铁纳米颗粒作为一种特异性 MRI 对比剂用于检测脑胶质瘤的体内研究
Biomaterials. 2011 Jan;32(2):495-502. doi: 10.1016/j.biomaterials.2010.09.024.
4
Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats.载阿霉素和汉防己甲素的乳铁蛋白修饰可生物降解聚合物囊用于治疗大鼠脑胶质瘤的化疗。
Mol Pharm. 2010 Dec 6;7(6):1995-2005. doi: 10.1021/mp100277h. Epub 2010 Oct 28.
5
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.乳铁蛋白修饰的前离子脂质体作为一种新型脑递药载体。
Eur J Pharm Sci. 2010 May 12;40(2):94-102. doi: 10.1016/j.ejps.2010.03.007. Epub 2010 Mar 16.
6
Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo.乳铁蛋白修饰的纳米颗粒可以介导基因在体内向大脑的有效传递。
Brain Res Bull. 2010 Apr 5;81(6):600-4. doi: 10.1016/j.brainresbull.2009.12.008. Epub 2009 Dec 22.
7
Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles.使用乳铁蛋白修饰的纳米颗粒对6-羟基多巴胺损伤的帕金森模型进行神经保护。
J Gene Med. 2009 Sep;11(9):754-63. doi: 10.1002/jgm.1361.
8
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.具有改善脑递送能力的乳铁蛋白共轭聚乙二醇-聚乳酸纳米颗粒:体外和体内评估
J Control Release. 2009 Feb 20;134(1):55-61. doi: 10.1016/j.jconrel.2008.10.016. Epub 2008 Nov 12.
9
Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.乳铁蛋白可诱导朊病毒蛋白在细胞表面滞留并抑制朊病毒积累。
J Neurochem. 2008 Nov;107(3):636-46. doi: 10.1111/j.1471-4159.2008.05628.x. Epub 2008 Sep 20.
10
The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.使用乳铁蛋白作为将基于聚酰胺-胺的基因递送系统靶向至大脑的配体。
Biomaterials. 2008 Jan;29(2):238-46. doi: 10.1016/j.biomaterials.2007.09.024.